Oncology Molecular Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00 – $ 8,900.00

Oncology Molecular Diagnostics Market: By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Others), By Product (Instruments, Reagents, Others), By Test Location ( Clinics and Other Establishments, Others), By Technology ( PCR, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips & Microarrays, Chips & Microarrays, Sequencing, Transcription Mediated Amplification, Others) and Geography

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Category: Healthcare Tag: Oncology Molecular Diagnostics Market

Description
Table Of Content
Company Profile

Report

Description

Oncology Molecular Diagnostics Market size is valued at USD 3.63 billion in 2021 and expected to reach a value of USD 8.32 billion by 2028, growing at a CAGR of 12.6% during the forecast period 2022-28 . The global market provides a detailed overview of the Oncology Molecular Diagnostics market and that can be segmented by type, product, test location, and technology. By type, The Oncology Molecular Diagnostics market has been segmented into Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, and Others. The Brest cancer segment is likely to be the largest and fastest-growing segment in terms of type. Based on product the Oncology Molecular Diagnostics Market is segmented into Instruments, Reagents, and Others. Among these, the reagents segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on the test location, the Oncology Molecular Diagnostics Market is segmented into Clinics and Other Establishments, Others. The clinic segment accounts for the largest share in 2021.

Key Development:

In February 2020, Danaher (Cepheid) announced a collaboration with Sherlock Biosciences to explore the innovative, ground-breaking molecular diagnostic test development intended for oncology and infectious diseases deploying CRISPR technology.

Oncology Molecular Diagnostics Market

MARKET SUMMARY

12.6% CAGR

Study Period– 2022-2028
Base Year– 2021
CAGR– 12.6%
Largest Market– North-America
Fastest Growing Market– Asia-Pacific

Oncology Molecular Diagnostics Market

The oncology molecular diagnostics market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
The oncology molecular diagnostics market is segmented based on product type, test location, technology and geography.

Key Players

Abbott Laboratories,
Bayer Healthcare AG,
Beckman Coulter, Inc.,
Cepheid, Inc
Becton, Dickinson and Company,

Oncology Molecular Diagnostics Market

Drivers

Increase in the prevalence of cancers such as breast cancer in women and prostate cancer is men is the major factor anticipated to burgeon the oncology molecular diagnostics market over the forecast years. Moreover, rise in R&D for the development of point of care diagnostic test kits, government initiatives for the cancer screening programs, and the launch of advanced test kits are immense boost to the market over the forecast timeframe.

North-America Got Significant Share

Oncology Molecular Diagnostics Market

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Oncology Molecular Diagnostics Market Segmentation

By Type

Breast Cancer,
Prostate Cancer,
Colorectal Cancer,
Cervical Cancer,
Liver Cancer,
Lung Cancer,
Blood Cancer,
Kidney Cancer,
Others

By Product Type

Instruments,
Reagents,
Others

By Technology

PCR,
In Situ Hybridization,
Isothermal Nucleic Acid Amplification Technology (INAAT),
Chips & Microarrays,
Chips & Microarrays,
Sequencing,
Transcription Mediated Amplification,
Others

Location

GEOGRAPHY

Frequently Asked Questions

The Oncology Molecular Diagnostics Market is projected to expand at a CAGR of 12.6% during the forecast period.

The major players in the global oncology molecular diagnostics market are Abbott Laboratories, Bayer Healthcare AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Cepheid, Inc., Danaher Corporation, Hologic, Inc., Leica Biosystems Inc., Qiagen NV, Roche Diagnostics (Schweiz) AG, Siemens Healthineers, Sysmex Corporation

Asia-Pacific is the fastest-growing region for Oncology Molecular Diagnostics Market

Report

Table Of Content

1. Executive Summary

2. Global Oncology Molecular Diagnostics Market Introduction

2.1. Global Oncology Molecular Diagnostics Market – Taxonomy

2.2. Global Oncology Molecular Diagnostics Market –Definitions

2.2.1. By Type

2.2.2. By Product

2.2.3. By Test Location

2.2.4. By Technology

2.2.5. By Region

3. Global Oncology Molecular Diagnostics Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Oncology Molecular Diagnostics Market Dynamic Factors – Impact Analysis

3.6. Global Oncology Molecular Diagnostics Market – Competition Landscape

3.7. Epidemiology Data

4. Global Oncology Molecular Diagnostics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028

4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Oncology Molecular Diagnostics Market, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.1. Breast Cancer

5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Prostate Cancer

5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Colorectal Cancer

5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

5.4. Cervical Cancer

5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

5.5. Liver Cancer

5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.5.3. Market Opportunity Analysis

5.6. Lung Cancer

5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.6.3. Market Opportunity Analysis

5.7. Blood Cancer

5.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.7.3. Market Opportunity Analysis

5.8. Kidney Cancer

5.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.8.3. Market Opportunity Analysis

5.9. Others

5.9.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.9.3. Market Opportunity Analysis

6. Global Oncology Molecular Diagnostics Market, By Product, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.1. Instruments

6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Reagents

6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Others

6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

7. Global Oncology Molecular Diagnostics Market, By Test Location, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.1. Clinics and Other Establishments

7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Others

7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

8. Global Oncology Molecular Diagnostics Market, By Technology, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.1. PCR

8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. In Situ Hybridization

8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Isothermal Nucleic Acid Amplification Technology (INAAT)

8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Chips & Microarrays

8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Mass Spectroscopy

8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

8.6. Sequencing

8.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.6.3. Market Opportunity Analysis

8.7. Transcription Mediated Amplification

8.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.7.3. Market Opportunity Analysis

8.8. Others

8.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

8.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.8.3. Market Opportunity Analysis

9. Global Oncology Molecular Diagnostics Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.1. North America

9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Europe

9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Asia-Pacific

9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

9.4. Latin America

9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.4.3. Market Opportunity Analysis

9.5. Middle East and Africa

9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.5.3. Market Opportunity Analysis

9.6. Global Oncology Molecular Diagnostics Market – Opportunity Analysis Index, By Type, By Resin, By Application, and Region, 2022 – 2028

10. North America Oncology Molecular Diagnostics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

10.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Breast cancer

10.1.2. Prostate cancer

10.1.3. Colorectal cancer

10.1.4. Cervical cancer

10.1.5. Liver cancer

10.1.6. Lung cancer

10.1.7. Blood cancer

10.1.8. Kidney cancer

10.1.9. Others

10.2. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. Instruments

10.2.2. Reagents

10.2.3. Others

10.3. Test Location Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. Clinics and other establishments

10.3.2. Point of Care

10.4. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.4.1. PCR

10.4.1.1. Multiplex

10.4.1.2. Others

10.4.2. In Situ Hybridization

10.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)

10.4.4. Chips and microarrays

10.4.5. Mass spectrometry

10.4.6. Sequencing

10.4.7. Transcription Mediated Amplification

10.4.8. Others

10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.5.1. U.S.

10.5.2. Canada

10.6. North America Oncology Molecular Diagnostics Market – Opportunity Analysis Index, By Type, Product, Test Location, Technology, And Country, 2022 – 2028

10.7. North America Oncology Molecular Diagnostics Market Dynamics – Trends

11. Europe Oncology Molecular Diagnostics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

11.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Breast cancer

11.1.2. Prostate cancer

11.1.3. Colorectal cancer

11.1.4. Cervical cancer

11.1.5. Liver cancer

11.1.6. Lung cancer

11.1.7. Blood cancer

11.1.8. Kidney cancer

11.1.9. Others

11.2. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. Instruments

11.2.2. Reagents

11.2.3. Others

11.3. Test Location Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Clinics and other establishments

11.3.2. Point of Care

11.4. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.4.1. PCR

11.4.1.1. Multiplex

11.4.1.2. Others

11.4.2. In Situ Hybridization

11.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)

11.4.4. Chips and microarrays

11.4.5. Mass spectrometry

11.4.6. Sequencing

11.4.7. Transcription Mediated Amplification

11.4.8. Others

11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.5.1. Germany

11.5.2. UK

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Russia

11.5.7. Poland

11.5.8. Rest of Europe

11.6. Europe Oncology Molecular Diagnostics Market – Opportunity Analysis Index, By Type, Product, Test Location, Technology, And Country, 2022 – 2028

11.7. Europe Oncology Molecular Diagnostics Market Dynamics – Trends

12. Asia-Pacific Oncology Molecular Diagnostics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Breast cancer

12.1.2. Prostate cancer

12.1.3. Colorectal cancer

12.1.4. Cervical cancer

12.1.5. Liver cancer

12.1.6. Lung cancer

12.1.7. Blood cancer

12.1.8. Kidney cancer

12.1.9. Others

12.2. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.2.1. Instruments

12.2.2. Reagents

12.2.3. Others

12.3. Test Location Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1. Clinics and other establishments

12.3.2. Point of Care

12.4. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.4.1. PCR

12.4.1.1. Multiplex

12.4.1.2. Others

12.4.2. In Situ Hybridization

12.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)

12.4.4. Chips and microarrays

12.4.5. Mass spectrometry

12.4.6. Sequencing

12.4.7. Transcription Mediated Amplification

12.4.8. Others

12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.5.1. Japan

12.5.2. China

12.5.3. India

12.5.4. ASEAN

12.5.5. Australia & New Zealand

12.5.6. Rest of Asia-Pacific

12.6. Asia-Pacific Oncology Molecular Diagnostics Market – Opportunity Analysis Index, By Type, Product, Test Location, Technology, And Country, 2022 – 2028

12.7. Asia-Pacific Oncology Molecular Diagnostics Market Dynamics – Trends

13. Latin America Oncology Molecular Diagnostics Market Analysis, 2017 – 2021 and Forecast, 2020 – 2026

13.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Breast cancer

13.1.2. Prostate cancer

13.1.3. Colorectal cancer

13.1.4. Cervical cancer

13.1.5. Liver cancer

13.1.6. Lung cancer

13.1.7. Blood cancer

13.1.8. Kidney cancer

13.1.9. Others

13.2. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.2.1. Instruments

13.2.2. Reagents

13.2.3. Others

13.3. Test Location Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1. Clinics and other establishments

13.3.2. Point of Care

13.4. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.4.1. PCR

13.4.1.1. Multiplex

13.4.1.2. Others

13.4.2. In Situ Hybridization

13.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)

13.4.4. Chips and microarrays

13.4.5. Mass spectrometry

13.4.6. Sequencing

13.4.7. Transcription Mediated Amplification

13.4.8. Others

13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Argentina

13.5.4. Rest of Latin America

13.6. Latin America Oncology Molecular Diagnostics Market – Opportunity Analysis Index, By Type, Product, Test Location, Technology, And Country, 2022 – 2028

13.7. Latin America Oncology Molecular Diagnostics Market Dynamics – Trends

14. Middle East and Africa Oncology Molecular Diagnostics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

14.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.1.1. Breast cancer

14.1.2. Prostate cancer

14.1.3. Colorectal cancer

14.1.4. Cervical cancer

14.1.5. Liver cancer

14.1.6. Lung cancer

14.1.7. Blood cancer

14.1.8. Kidney cancer

14.1.9. Others

14.2. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.2.1. Instruments

14.2.2. Reagents

14.2.3. Others

14.3. Test Location Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.3.1. Clinics and other establishments

14.3.2. Point of Care

14.4. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.4.1. PCR

14.4.1.1. Multiplex

14.4.1.2. Others

14.4.2. In Situ Hybridization

14.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)

14.4.4. Chips and microarrays

14.4.5. Mass spectrometry

14.4.6. Sequencing

14.4.7. Transcription Mediated Amplification

14.4.8. Others

14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

14.5.1. Gulf Cooperation Council (GCC) Countries

14.5.2. Israel

14.5.3. South Africa

14.5.4. Rest of MEA

14.6. MEA Oncology Molecular Diagnostics Market – Opportunity Analysis Index, By Type, Product, Test Location, Technology, And Country, 2022 – 2028

14.7. MEA Oncology Molecular Diagnostics Market Dynamics – Trends

15. Competition Landscape

15.1. Strategic Dashboard of Top Market Players

15.1.1. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)

15.1.2. Abbott Laboratories

15.1.3. Bayer Healthcare AG

15.1.4. Beckman Coulter, Inc.

15.1.5. Becton, Dickinson and Company

15.1.6. Cepheid, Inc.

15.1.7. Danaher Corporation

15.1.8. Hologic, Inc.

15.1.9. Leica Biosystems Inc.

15.1.10. Qiagen NV

15.1.11. Roche Diagnostics (Schweiz) AG

15.1.12. Siemens Healthineers

15.1.13. Sysmex Corporation

16. Research Methodology

17. Key Assumptions and Acronyms

Description

search

Oncology Molecular Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

Description

Key Development:

Oncology Molecular Diagnostics Market

Drivers

Oncology Molecular Diagnostics Market

By Type

By Product Type

By Technology

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Key Development:

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE